Lotan R - Search Results

1

Retinoid receptor-dependent and -independent effects of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cells.

Clifford JL, Menter DG, Wang M, Lotan R, Lippman SM. Clifford JL, et al. Among authors: lotan r. Cancer Res. 1999 Jan 1;59(1):14-8. Cancer Res. 1999. PMID: 9892176

2

GATA-6 transcriptional regulation of 15-lipoxygenase-1 during NSAID-induced apoptosis in colorectal cancer cells.

Shureiqi I, Jiang W, Fischer SM, Xu X, Chen D, Lee JJ, Lotan R, Lippman SM. Shureiqi I, et al. Among authors: lotan r. Cancer Res. 2002 Feb 15;62(4):1178-83. Cancer Res. 2002. PMID: 11861401

3

Phase II clinical trial of N-(4-Hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasia.

Singletary SE, Atkinson EN, Hoque A, Sneige N, Sahin AA, Fritsche HA Jr, Lotan R, Lu T, Hittelman WN, Bevers TB, Stelling CB, Lippman SM. Singletary SE, et al. Among authors: lotan r. Clin Cancer Res. 2002 Sep;8(9):2835-42. Clin Cancer Res. 2002. PMID: 12231524 Clinical Trial.

4

Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolites.

Sabichi AL, Xu H, Fischer S, Zou C, Yang X, Steele VE, Kelloff GJ, Lotan R, Clifford JL. Sabichi AL, et al. Among authors: lotan r. Clin Cancer Res. 2003 Oct 1;9(12):4606-13. Clin Cancer Res. 2003. PMID: 14555536

5

RRIG1 mediates effects of retinoic acid receptor beta2 on tumor cell growth and gene expression through binding to and inhibition of RhoA.

Liang ZD, Lippman SM, Wu TT, Lotan R, Xu XC. Liang ZD, et al. Among authors: lotan r. Cancer Res. 2006 Jul 15;66(14):7111-8. doi: 10.1158/0008-5472.CAN-06-0812. Cancer Res. 2006. PMID: 16849557

6

Modulation by retinoic acid (RA) of squamous cell differentiation, cellular RA-binding proteins, and nuclear RA receptors in human head and neck squamous cell carcinoma cell lines.

Zou CP, Clifford JL, Xu XC, Sacks PG, Chambon P, Hong WK, Lotan R. Zou CP, et al. Among authors: lotan r. Cancer Res. 1994 Oct 15;54(20):5479-87. Cancer Res. 1994. PMID: 7522960

7

Anti-retinoic acid (RA) antibody binding to human premalignant oral lesions, which occurs less frequently than binding to normal tissue, increases after 13-cis-RA treatment in vivo and is related to RA receptor beta expression.

Xu XC, Zile MH, Lippman SM, Lee JS, Lee JJ, Hong WK, Lotan R. Xu XC, et al. Among authors: lotan r. Cancer Res. 1995 Dec 1;55(23):5507-11. Cancer Res. 1995. PMID: 7585623

8

p53 and retinoid chemoprevention of oral carcinogenesis.

Lippman SM, Shin DM, Lee JJ, Batsakis JG, Lotan R, Tainsky MA, Hittelman WN, Hong WK. Lippman SM, et al. Among authors: lotan r. Cancer Res. 1995 Jan 1;55(1):16-9. Cancer Res. 1995. PMID: 7805028 Clinical Trial.

9

Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues.

Mao L, El-Naggar AK, Fan YH, Lee JS, Lippman SM, Kayser S, Lotan R, Hong WK. Mao L, et al. Among authors: lotan r. Cancer Res. 1996 Dec 15;56(24):5600-4. Cancer Res. 1996. PMID: 8971162

10

Retinoid-interferon therapy of solid tumors.

Lippman SM, Lotan R, Schleuniger U. Lippman SM, et al. Among authors: lotan r. Int J Cancer. 1997 Feb 7;70(4):481-3. doi: 10.1002/(sici)1097-0215(19970207)70:4<481::aid-ijc20>3.0.co;2-h. Int J Cancer. 1997. PMID: 9033661 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

468 results

Search Page

Filters